The present disclosure relates to microbial compositions for enhancing bile acid metabolism in a subject, methods of manufacturing the compositions, and methods of selecting subjects in need of treatment with the compositions. Certain bile acid transforming or converting genes and bile acid transforming or converting bacteria are used to select desired bacterial isolates or suitable donors or patients, predict treatment success, or track treatment response.